Download PDF
Synlett 2008(3): 343-346  
DOI: 10.1055/s-2008-1032042
LETTER
© Georg Thieme Verlag Stuttgart · New York

A Practical Synthetic Route to Benzofuro[2,3-b]pyridine and Trifluoromethyl-α-carbolines

Viktor O. Iaroshenko*a,b, Ulrich Grotha, Nadiya V. Kryvokhyzhac, Samra Obeida, Andrei A. Tolmachevb,d, Thomas Wescha
a Fachbereich Chemie, Universität Konstanz, Fach M-720, Universitätsstraße 10, 78457 Konstanz, Germany
Fax: +49(7531)884424; e-Mail: yva108@yahoo.co.uk;
b National Taras Shevchenko University, 62 Volodymyrska st., Kyiv 33, 01033, Ukraine
c Department of Chemistry, University of Glasgow, University Avenue, Glasgow, G12 8QQ, UK
d ‘Enamine Ltd.’, 23 A. Matrosova st., 01103 Kyiv, Ukraine
Further Information

Publication History

Received 25 September 2007
Publication Date:
16 January 2008 (online)

    Permissions and Reprints All articles of this category

Abstract

In situ generated benzofuran-2-amine reacts with 1,3-CCC-dielectrophiles, such as CF3-containing β-diketones, 3-formylchromone, methyl-2,4-dioxopentanoate and pentafluoro­benzaldehyde, and the reaction leads to the formation of benzofuro[2,3-b]pyridine ring system. By using a similar approach 4-trifluoromethyl-α-carbolines were synthesized starting from indole-2-amine.

Key words

furanamine - indoleamine - pyridine - annulation - electrophilic aromatic substitution

    References and Notes

  • 1a Kovtunenko VO. Drug Methods Acting on the Central Nervous System [in Ukrainian]   Perun; Kiev: 1997.  p.373 
    Google Scholar
  • 1b Silverman RB. The Organic Chemistry of Drug Design, and Drug Action   2nd ed.:  Elsevier/Academic Press; New York: 2004.  p.617 
    Google Scholar
  • 2a Kleemann A. Engel J. Kutscher B. Reichert D. Pharmaceutical Substances: Syntheses, Patents, Applications   Thieme; Stuttgart: 2001. 
    CrossrefGoogle Scholar
  • 2b Ismail FMD. J. Fluorine Chem.  2002,  118:  27 
    CrossrefGoogle Scholar
  • 3a Venkat RG, Qi L, Pierce M, Robbins PB, Sahasrabudhe SR, and Selliah R. inventors; Int. Patent  WO2007076085.  ; Chem. Abstr. 2007, 147, 143456
    CrossrefPubMed
  • 3b Arakawa H, Monden Y, Nakatsuru Y, and Kodera T. inventors; Int. Patent  WO2003080077.  ; Chem. Abstr. 2003, 139, 286323
    CrossrefPubMed
  • 3c Burstein HJ. Overmoyer B. Gelman R. Silverman P. Savoie J. Clarke K. Dumadag L. Younger J. Ivy P. Winer EP. Invest. New Drugs  2007,  25:  161 
    CrossrefPubMedGoogle Scholar
  • 4a Yan H. Mizutani TC. Nomura N. Takakura T. Kitamura Y. Miura H. Nishizawa M. Tatsumi M. Yamamoto N. Sugiura W. Antiviral Chem. Chemother.  2005,  16:  363 
    Google Scholar
  • 4b Li X. Vince R. Bioorg. Med. Chem.  2006,  14:  2942 
    Google Scholar
  • 4c Zhao G. Wang C. Liu C. Lou H. Mini-Rev. Med. Chem.  2007,  7:  707 
    Google Scholar
  • 5a Gelbard HA, Maggirwar SB, Dewhurst S, and Schifitto GP. inventors; Int. Patent  WO2007076372.  ; Chem. Abstr. 2007, 147, 134456
  • 5b Mellman I, and Jiang A. inventors; Int. Patent  WO2007075911.  ; Chem. Abstr. 2007, 147, 134427
  • 6a Stubbs MC. Armstrong SA. Curr. Drug Targets  2007,  8:  703 
    CrossrefGoogle Scholar
  • 6b Shenoy S. Vasania VS. Gopal M. Mehta A. Toxicol. Appl. Pharmacol.  2007,  222:  80 
    CrossrefGoogle Scholar
  • 6c Seedhouse CH. Hunter HM. Lloyd-Lewis B. Massip A.-M. Pallis M. Carter GI. Grundy M. Shang S. Russell NH. Leukemia  2006,  20:  2130 
    CrossrefGoogle Scholar
  • 7a Joseph J, Meijer L, and Liger F. inventors; Fr. Patent  FR2876377.  ; Chem. Abstr. 2006, 144, 390900
  • 7b Sennhenn P, Mantoulidis A, Treu M, Tontsch-Grunt U, Spevak W, McConnell D, Schoop A, Brueckner R, Jacobi A, Guertler U, Schnapp G, Klein C, Himmelsbach F, Pautsch A, Betzemeier B, Herfurth L, Mack J, Wiedenmayer D, Bader G, and Reiser U. inventors; Int. Patent  WO2006131552.  ; Chem. Abstr. 2006, 146, 62695
  • 7c Das S, Brown JW, Dong Q, Gong X, Kaldor SW, Liu Y, Paraselli BR, Scorah N, Stafford JA, and Wallace MB. inventors; Int. Patent  W02007044779.  Chem. Abstr. 2007, 146, 441771
  • 8 Fong TM, Erondu NE, Macneil DJ, Mcintyre JH, and Van der Ploeg LHT. inventors; Int. Patent  WO2004110368.  ; Chem. Abstr. 2004, 142, 69181
  • 9a Voigt B. Meijer L. Lozach O. Schaechtele C. Totzke F. Hilgeroth A. Bioorg. Med. Chem. Lett.  2005,  15:  823 
    CrossrefPubMedGoogle Scholar
  • 9b Xie Y, Zhang G, Wang X, Gray NS, and Liu Y. inventors; Int. Patent  WO2007021795.  ; Chem. Abstr. 2007, 146, 274386
    CrossrefPubMed
  • 10 Brachwitz K. Hilgeroth A. Bioorg. Med. Chem. Lett.  2002,  12:  411 
    CrossrefPubMedGoogle Scholar
  • 11 Resnati G. Tetrahedron  1993,  49:  9385 
    CrossrefGoogle Scholar
  • 12a Mueller U, Connell R, Goldmann S, Gruetzmann R, Beuck M, Bischoff H, Denzer D, Domdey-Bette A, and Wohlfeil S. inventors; Eur. Patent  EP705831.  ; Chem. Abstr. 1996, 125, 58487
  • 12b Gruetzmann R, Mueller U, Bischoff H, and Zaiss S. inventors; Int. Patent  WO2001097787.  ; Chem. Abstr. 2001, 136, 64132
  • 13a Volochnyuk DM. Pushechnikov AO. Krotko DG. Sibgatulin DA. Kovalyova SA. Tolmachev AA. Synthesis  2003,  1531 
    Article in Thieme ConnectGoogle Scholar
  • 13b Volochnyuk DM. Kostyuk AN. Sibgatulin DA. Chernega AN. Tetrahedron  2005,  61:  2839 
    Article in Thieme ConnectGoogle Scholar
  • 13c Iaroshenko VO. Volochnyuk DM. Wang Y. Vovk MV. Boiko VJ. Rusanov EB. Groth UM. Tolmachev AO. Synthesis  2007,  3309 
    Article in Thieme ConnectGoogle Scholar
  • 14 Glenn RW, Lim M, Gardlik JM, Jones SD, Murphy BP, and Rees CW. inventors; US Patent  US2005193504.  ; Chem. Abstr. 2005, 143, 292010
  • 15 Cruz F. Quijano L. Gomez-Garibay F. Rios T. J. Nat. Prod.  1990,  53:  543 
    CrossrefGoogle Scholar
  • 16a Pschorr R. Hoppe G. Ber. Dtsch. Chem. Ges.  1910,  43:  2543 
    CrossrefGoogle Scholar
  • 16b Matsumoto T. Yoshida D. Tomita H. Agric. Biol. Chem.  1981,  45:  2031 
    CrossrefGoogle Scholar
  • 16c Sagitullin RS. Mel’nikova TV. Kost AN. Snegirev VF. Frenkel EN. Khim. Geterotsikl. Soedin.  1973,  8:  1043 
    CrossrefGoogle Scholar
  • 16d Portnov YN, Golubeva GA, and Kost AN. inventors; SU Patent  SU331060.  ; Chem. Abstr. 1972, 77, 19720307
    Crossref
  • 16e Kebrle J. Hoffmann K. Helv. Chim. Acta  1956,  39:  116 
    CrossrefGoogle Scholar
  • 17a Pfister JR. Wyman WE. Synthesis  1983,  38 
    CrossrefGoogle Scholar
  • 17b Capson TL. Poulter CD. Tetrahedron Lett.  1984,  25:  3515 
    CrossrefGoogle Scholar
  • 17c Wang X.-C. Chai L.-Q. Wang M.-G. Quan Z.-Q. Li Z. Synth. Commun.  2006,  36:  645 
    CrossrefGoogle Scholar
  • 17d Hu Y.-H. Xiang JS. Di-Grandi MJ. Du X. Ipek M. Laakso LM. Li J. Li W. Rush TS. Schmid J. Skotnicki JS. Bioorg. Med. Chem.  2005,  13:  6629 
    CrossrefGoogle Scholar
  • 20a Kost AN. Men’shikov VV. Sagitullin RS. Zh. Org. Khim.  1976,  12:  2234 
    CrossrefGoogle Scholar
  • 20b Sadovoy AV. Golubev GA. Nasakin OE. Chem. Heterocycl. Compd. (Engl. Transl.)  2001,  37:  1145 
    CrossrefGoogle Scholar
  • 20c Muller U, Eckenberg P, Grutzmann R, Bischoff H, Denzer D, Wohlfeil S, Lohmer S, Nielsch U, and Kolkhof P. inventors; Eur. Patent  EP799828.  ; Chem. Abstr. 1997, 127, 678930
    Crossref
  • 21a Gowravaram S. Aldrichimica Acta  1996,  29:  15 
    Google Scholar
  • 21b Ghosh T. Bandyopadhyay C. J. Heterocycl. Chem.  2006,  43:  1431 
    Google Scholar
  • 21c Quiroga J. Mejia D. Insuasty B. Abonia R. Nogueras M. Sanchez A. Cobo J. Low JN. J. Heterocycl. Chem.  2002,  39:  51 
    Google Scholar
  • 21d Ghosh CK. Ray A. Patra A. J. Heterocycl. Chem.  2001,  38:  1459 
    Google Scholar
  • 22a Jiang JB. Roberts J. J. Heterocycl. Chem.  1985,  22:  159 
    Google Scholar
  • 22b Jiang JB, and Isaacson D. inventors; US Patent  US4656274.  ; Chem. Abstr. 1987, 127, 318979
  • 24 Pento J. T., Li P.-K., Brueggemeier R. W., Hackett J.; Int. Patent WO2006119148, 2006; Chem. Abstr. 2006, 145, 489214
  • 26a Muthian S, Mnich SJ, Burgos LAC, and Naiman BM. inventors; Int. Patent  WO2007039797.  ; Chem. Abstr. 2007, 146, 375738
  • 26b Nunes JJ, Milne J, Bemis J, Xie R, Vu CB, Ng PY, Disch JS, Salzmann T, and Armistead D. inventors; Int. Patent  WO2007019346.  ; Chem. Abstr. 2007, 146, 274349
  • 26c Taltavull MJ, Pages S, and Luis M. inventors; Int. Patent  WO2007017078.  ; Chem. Abstr. 2007, 146, 229376
18

2-Methyl-4-(trifluoromethyl)benzofuro[2,3- b ]pyridine (5a): colorless solid (1.13 g, 90%); mp 115-117 °C; R f = 0.65 (EtOAc-hexane, 1:2). 1H NMR (400 MHz, DMSO-d 6): δ = 2.68 (s, 3 H), 7.50 (t, 3 J HH = 8.0 Hz, 1 H), 7.66 (t, 3 J HH = 8.0 Hz, 1 H), 7.73 (s, 1 H), 7.83 (d, 3 J HH = 8.0 Hz, 1 H), 7.99 (d, 3 J HH = 8.0 Hz, 1 H). 13C NMR (100.5 MHz, DMSO-d 6): δ = 24.4, 109.8, 112.7, 115.5, 119.7, 123.4, 123.7 (1 J CF = 275 Hz), 124.7, 126.7, 129.9 (2 J CF = 35 Hz), 154.5, 158.1, 163.1. 19F NMR (376.2 MHz, DMSO-d 6): δ = -63.5. MS: m/z (%) = 242 (14) [M+ + 1], 241 (100) [M+], 210 (37), 182 (41). Anal. Calcd for C13H8F3NO: C, 62.16; H, 3.21; N, 5.58. Found: C, 62.18; H, 3.20; N, 5.57.

19

General Procedure for the Synthesis of Furo[2,3- b ]pyridines 5, 9, 11, and benzofuro[2,3- b ]quinoline 13: To a boiling solution of AcOH (250 mL) and H2O (10 mL; temperature in the oil bath was about 135 °), a mixture of a dielectrophile (5 mmol) and 2-isocyanatobenzofuran (1.99 g, 12.5 mmol) in absolute DMF (50 mL) was dropped very slowly through the condenser. After the addition was completed the mixture was refluxed for further 3 h. After evaporation of the solvent, the residue was subjected to column chromatography over silica gel, or recrystallized from appropriate solvent.

23

7,8,9,10-Tetrafluorobenzofuro[2,3- b ]quinoline (13): colorless solid (1.05 g, 72%); mp 235-237 °C (i-PrOH). 1H NMR (400 MHz, DMSO-d 6): δ = 7.55 (t, 3 J HH = 8.0 Hz, 1 H), 7.74 (t, 3 J HH = 8.0 Hz, 1 H), 7.81 (d, 3 J HH = 8.0 Hz, 1 H), 8.40 (d, 3 J HH = 8.0 Hz, 1 H), 9.35 (s, 1 H). MS: m/z (%) = 292 (17) [M+ + 1], 291 (100) [M+], 262 (10), 145 (10). Anal. Calcd for C15H5F4NO: C, 61.87; H, 1.73; N, 4.81. Found: C, 61.85; H, 1.74; N, 4.82.

25

4-(Difluoromethyl)-2-methylbenzofuro[2,3- b ]pyridine (14a): colorless solid (0.99 g, 85%); mp 112-113 °C; R f = 0.5 (EtOAc-hexane, 1:2). 1H NMR (400 MHz, CDCl3): δ = 2.72 (s, 3 H), 7.04 (t, 2 J HF = 56 Hz, 1 H), 7.31 (s, 1 H), 7.39 (t, 3 J HH = 8.0 Hz, 1 H), 7.53 (t, 3 J HH = 8.0 Hz, 1 H), 7.63 (d, 3 J HH = 8.0 Hz, 1 H), 8.01 (d, 3 J HH = 8.0 Hz, 1 H). 13C NMR (100.5 MHz, CDCl3): δ = 24.5, 110.8, 112.4 (1 J CF = 240 Hz), 113.1, 115.5, 120.9, 123.4, 124.3, 128.6, 136.8 (2 J CF = 26 Hz), 154.6, 157.0, 163.4. 19F NMR (376.2 MHz, DMSO-d 6): δ = -115.3 (d, 2 J HF = 56 Hz, 2 F). MS: m/z (%) = 234 (15) [M+ + 1], 233 (100) [M+], 182 (16). Anal. Calcd for C13H9F2NO: C, 66.95; H, 3.89; N, 6.01. Found: C, 66.94; H, 3.89; N, 6.02.